# Preliminary Safety of The TRUE Vascular Graft for Hemodialysis Access (TRUE HD I Study)

> **NCT04905511** · PHASE1 · COMPLETED · sponsor: **Vascudyne, Inc.** · enrollment: 10 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **BIOLOGICAL:** natural human collagen arteriovenous graft for hemodialysis access

## Key facts

- **NCT ID:** NCT04905511
- **Lead sponsor:** Vascudyne, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-10
- **Primary completion:** 2022-02-15
- **Final completion:** 2022-06-15
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04905511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04905511, "Preliminary Safety of The TRUE Vascular Graft for Hemodialysis Access (TRUE HD I Study)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04905511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*